Remove initiatives regulatory commenting ispe
article thumbnail

Asia-Pacific Regulatory & Industry Views on Drug Shortage Prevention

ISPE

Regulatory speakers were Lisa Hedman, Group Lead for the Division of Supply and Access to Medicines of the World Health Organization (WHO); and Joyce Cirunay, Director IV of the Center for Drug Regulation and Research at the Philippines FDA. Hustead Executive Director, Regulatory Affairs Merck & Co.,

article thumbnail

The Journey to Quality Management Maturity: ISPE European Conference keynote and ISPE APQ Program

ISPE

This year was a major success with a wide range of topics addressing advancements in technology and policy initiatives that are transforming the pharmaceutical manufacturing landscape. ISPE conferences provide unique opportunities for engagement and open dialog with global regulatory agencies.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Communities of Practice Profiles: Shaping the Future of the Combination Products Industry

ISPE

Combination Products is one of ISPE’s newest Communities of Practice (CoPs). The regulatory frameworks for these products vary from country to country. In the US, each constituent part retains its regulatory identity in a combination product. Why Is Your Communities of Practice’s Work Critical to ISPE and the Industry?

FDA 52
article thumbnail

2022 ISPE Annual Meeting: New Chair, New Year of ISPE Initiatives

ISPE

2022 ISPE Annual Meeting: New Chair, New Year of ISPE Initiatives. 2022 ISPE Annual Meeting: New Chair, New Year of ISPE Initiatives. The gavel passed to a new International Board Chair and ISPE leaders shared 2022 achievements and plans for 2023 at the 2022 ISPE Membership Meeting and Awards Lunch.

article thumbnail

GAMP 5 update: computerized system expectations for pharma manufacturers

European Pharmaceutical Review

As ISPE GAMP 5 Second Edition notes in the preface “Operating in a highly regulated industry may lead practitioners to apply prescriptive and rigid compliance-based approaches that are not commensurate with and not effective in managing any actual risk to the product and the patient.”

article thumbnail

EMA Executive Director Speaks on the Value of Adaptation, Trust, & Collaboration

ISPE

Cooke, who has over 30 years of experience in international regulatory affairs, with 18 years in leadership roles, took the helm at EMA as director in November 2020, early in the pandemic, after having worked at EMA since 2002, serving as head of inspections initially and then as head of international affairs from 2009 to 2016.

article thumbnail

2022 ISPE Annual Meeting & Expo Opening Keynotes Focus on Quality, Transformation, and Patients

ISPE

2022 ISPE Annual Meeting & Expo Opening Keynotes Focus on Quality, Transformation, and Patients. 2022 ISPE Annual Meeting & Expo Opening Keynotes Focus on Quality, Transformation, and Patients. Many products launch globally, and regulatory strategies must be data-driven and risk-based. Trudy Patterson. Tue, 11/01/2022 - 06:49.

FDA 98